Simultaneous analytical measurement of multiple protein biomarkers continues to hold promise in the identification of molecular signatures that may impact research applications, ranging from ...
The immunoassay—a mainstay of life sciences and clinical diagnostic laboratories—detects and quantifies proteins and other kinds of molecules in complex samples, usually through the use of antibodies.
A quantitative reverse transcriptase polymerase chain reaction assay to identify metastatic carcinoma tissue of origin No significant financial relationships to disclose. This is an ASCO Meeting ...
Stroke is among the most common neurologic disorders and a leading cause of death anddisability worldwide. Among the most long-lasting consequences of stroke and cerebrovasculardisease is cognitive ...
The "Multiplex Assays Market by Type (Protein [Bead, Planar], Nucleic Acid, Cell), Technology (Flow Cytometry, PCR, Immunoassay), Application (R&D, Diagnosis ...
Messenger molecules such as cytokines are involved in the communication within the immune system and play a vital role in a variety of conditions including cancer and autoimmune diseases. Advancing ...
Reverse phase protein array is a high-throughput technology that performs protein assays on thousands of samples simultaneously, including tissue and cell lysates, serum, plasma or other body fluids.
Hematuria may occur in up to 10% of the general population and results in costly evaluation to ensure it is of no consequence, i.e., no bladder cancer (BCa) is present since hematuria is typically the ...
Thermo Fisher Scientific is rolling out a research test to profile dozens of proteins linked to neurodegenerative diseases—such as Alzheimer’s, Parkinson’s, ALS, multiple sclerosis and others—with the ...